| (EUR) | Dec 2025 | Y/Y change |
|---|---|---|
| Revenue | 8.83M | 4.42% |
| Operating expense | — | — |
| Net income | -6.33M | -0.13% |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, HYL.BR returned -33.1% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -34.5% |
| 1 year | -33.1% |
| 5 years | -67.3% |
| All-time high | €17.30 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in HYL.BR would be worth today ›No. Hyloris Pharmaceuticals SA has not paid a dividend in the past 12 months.
Hyloris Pharmaceuticals SA is part of the Healthcare sector.
Hyloris Pharmaceuticals SA has a market cap of 125.44M EUR, based on the latest quote.
Hyloris Pharmaceuticals SA is scheduled to report earnings on Sep 24, 2026.
